REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. (Nasdaq: REVB) is a clinical-stage life sciences company that entered the public markets through a merger with Pono Capital Two Corp, a blank-check vehicle sponsored by Pono Capital LLC that completed its initial public offering in 2021. The company is focused on modulating the innate immune system to address infectious disease and related conditions. On May 11, 2026, Revelation Biosciences filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission, indicating an upcoming shareholder meeting covering routine governance matters such as director elections and executive compensation. Investors and analysts seeking comprehensive filing histories, SPAC merger data, and corporate action tracking for REVB can sign up for full coverage on SpacDesk.